Correlation between Urinary Iodine and Thyroid Diseases
-
摘要:
目的 探究甲状腺疾病与尿碘等指标的相关性及甲状腺疾病发生的危险因素。 方法 以2018年1月至12月于昆明市第一人民医院甘美医院内分泌科体检和就诊的患者共266例,将其分为有甲状腺疾病组(207例)和非甲状腺疾病组(59例),并测定尿碘、促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状素(FT4)、三碘甲状腺原氨酸(T3)、四碘甲状腺原氨酸(T4)、甲状腺过氧化物酶抗体(TPOAb)、甲状腺球蛋白抗体(TGAb)水平,应用彩色多普勒超声对研究对象的甲状腺进行检测。采用SPSS17.0软件进行t检验、秩和检验、χ2检验,甲状腺疾病的患病影响因素采用多因素Logistic回归分析。 结果 (1)甲状腺疾病组的尿碘水平中位数(143.30 μug/L)低于非甲状腺疾病组(178.30 μg/L),差异有统计学意义(P < 0.05);(2)多因素Logistic回归分析结果显示,年龄( OR 1.140、95%CI:1.033-1.257、P = 0.009)、尿碘(OR 0.983、95%CI:0.971-0.996、P = 0.008)及TPOAb(OR 1.018、95%CI:0.979-1.059、P = 0.020)为甲状腺疾病的独立危险因素。 结论 低水平尿碘与甲状腺疾病的患病有关,尿碘、TPOAb和年龄是甲状腺疾病的独立危险因素。 -
关键词:
- 尿碘 /
- 甲状腺过氧化酶抗体(TPOAb) /
- 甲状腺疾病
Abstract:Objective To investigate the correlation between urinary iodine and thyroid diseases. Method A total of 266 patients who received physical check-up or treatment in the Department of Endocrinology of our hospital from January to December 2018 were enrolled in the study. Patients were divided into a thyroid disease group (207 cases) and non thyroid disease group (59 cases); and urine iodine and thyroid stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroid Levels of FT4, triiodothyronine (T3), tetraiodothyronine (T4), thyroid peroxidase antibody (TPOAb), thyroglobulin antibody (TGAb) level are detected. Color doppler ultrasound was used to check patients thyroid. SPSS17.0 software was used for t test, rank sum test and χ2 test; and multivariate Logistic regression analysis was used for the incidence factors of thyroid diseases. Results The median urinary iodine level (143.30 ug/L) of the thyroid disease group was significantly lower than that of the non-thyroid disease group (178.30 ug/L, P < 0.05); multivariate logistic regression analysis results showed that age ( OR= 1.140, 95%CI: 1.033-1.257, P = 0.009), urine iodine (OR= 0.983, 95%CI: 0.971-0.996, P = 0.008) and TPOAb (OR = 1.018, 95%CI: 0.979-1.059, P = 0.020) were independent risk factors for thyroid disease. Conclusion Low levels of urinary iodine are related to the prevalence of thyroid diseases. Urinary iodine, TPOAb and age are independent risks factors of thyroid diseases. -
Key words:
- Urinary iodine /
- Thyroid peroxidase antibody(TPOAb) /
- Thyroid disease
-
表 1 一般资料比较
Table 1. General information of the two groups
因素 无甲状腺疾病组 有甲状腺疾病组 性别(男/女) 18/41 38/169 身高(m) 1.64 ± 0.078 1.63 ± 0.068 体重(kg) 59.48 ± 10.05 59.64 ± 7.42 体重指数(kg/m2) 21.97 ± 2.30 22.50 ± 1.94 年龄(岁) 33.00(28.00,42.00) 42.00(34.00,55.00) T4(nmol/L) 92.30(80.20,112.60) 102.10(89.50,121.50) FT4(pmol/L) 14.77(13.73,16.71) 14.75(13.13,16.49) T3(nmol/L) 1.58(1.43,1.75) 1.62(1.41,1.80) FT3(pmol/L) 4.73(4.21,5.07) 4.63(4.21,5.11) TSH(mIU/L) 2.43(1.78,3.58) 2.96(1.55,5.16) TPOAb(IU/mL) 30.80(28.00,37.60) 539.30(43.10, 1300.00 )TGAb(IU/mL) 19.00(16.00,23.20) 38.60(17.00,274.3) 尿碘(µg/L) 178.30(136.40.241.10) 143.30(89.50,212.00) 表 2 甲状腺疾病危险因素的多因素Logistic回归分析结果
Table 2. Multivariate logistic regression analysis of risk factors of thyroid diseases
因素 B P OR 95%CI 年龄(岁) 0.131 0.009 1.140 1.033~1.257 尿碘(µg/L) −0.017 0.008 0.983 0.971~0.996 T4(nmol/L) 0.003 0.856 1.003 0.971~1.037 TPOAb(IU/mL) 0.018 0.020 1.018 0.979~1.059 TGAb(IU/mL) 0.078 0.062 1.081 0.966~1.173 性别 2.719 0.146 15.172 0.395~59.695 -
[1] 梁建. 我国云南最早尝试食盐加碘防治碘缺乏病的历史[J]. 中华地方病学杂志,2009,38(2):165-167. doi: 10.3760/cma.j.issn.1000-4955.2009.02.013 [2] 腾卫平. 防治碘缺乏病与碘过量[J]. 中华内分泌代谢杂志,2002,18(3):239-242. [3] 孙川喻,陆烨君,阮慧娟,等. 成人碘营养状况评价以及与甲状腺结节的相关性[J]. 中华临床营养杂志,2016,24(2):76-81. [4] Konig F,Andersson M,Hotz K,et al. Ten repeat collections for urinary iodine from spot samples or 24-hour samples are needed to reliably estimate individual iodine status in women[J]. The Journal of Nutrition,2011,141(11):2049-2054. doi: 10.3945/jn.111.144071 [5] 陈赟. 尿碘与甲状腺疾病相关性研究进展[J]. 临床与病理杂志,2016,36(9):1423-1429. doi: 10.3978/j.issn.2095-6959.2016.09.034 [6] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 中国甲状腺疾病诊治指南—碘缺乏病[J]. 中华内科杂志,2008,47(8):689-690. [7] 滕卫平. 再论碘摄入量增加对甲状腺疾病的影响[J]. 中华内分泌代谢杂志,2001,17(2):69-70. doi: 10.3760/j.issn:1000-6699.2001.02.002 [8] 孙殿军. 论中国地方病控制之前景[J]. 中国地方病学杂志,2009,28(1):3-6. [9] 王安伟,黄文丽,叶枫,等. 云南省食盐碘含量调整前后儿童碘营养状况调查[J]. 中华地方病学杂志,2018,37(1):49-53. doi: 10.3760/cma.j.issn.2095-4255.2018.01.011 [10] 陈冬,邓大同,陈明卫. TPO/TPO抗体与甲状腺疾病相关性[J]. 安徽医药,2011,15(1):1-3. doi: 10.3969/j.issn.1009-6469.2011.01.001 [11] Dong Y H,Fu D G. Autoimmune thyroid disease:Mechanism,genetics and current knowledge[J]. Eur Rev Med Pharmacol Sci,2014,18(23):3611-3618. [12] 刘婷婷,滕卫平. 中国国民碘营养现状与甲状腺疾病[J]. 中华内科杂志,2017,56(1):62-64. doi: 10.3760/cma.j.issn.0578-1426.2017.01.018 [13] 王娟娟,贾清珍,张向东,等. 尿碘与甲状腺疾病相关性的研究[J]. 中华地方病学杂志,2013,32(4):359-361. doi: 10.3760/cma.j.issn.2095-4255.2013.04.002 [14] 薛利敏. 女性自身免疫性甲状腺炎患者的尿碘水平及硒、碘干预效果评价[D]. 唐山: 华北理工大学硕士学位论文, 2017.